Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients
Status:
Unknown status
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine viable use of caspofungin in post-OLTx patients, and to
demonstrate in particular the effectiveness, understood as the ability to reduce the
incidence of invasive fungal infections, and to assess the ability to reduce the risk and
incidence of side effects (toxicity) which may arise in transplant patients treated with
other drugs, especially in individuals recognized as high risk (e.g. renal failure).